Chemomab Therapeutics Ltd. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €23.08K
    Gross profit
    -€23.08K
    SG&A expenses
    €3.01M
    R&D expenses
    €9.15M
    EBITDA
    -€12.16M
    D&A
    €51.69K
    EBIT
    -€12.16M
    Interest expenses
    €0.00
    EBT
    -€11.50M
    Tax expenses
    €0.00
    Net income
    -€11.50M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €11.50M
    Changes in working capital
    €0.00
    Operating cash flow
    €0.00
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    €0.00

    Balance sheet

    Cash and cash equivalents
    €7.15M
    Cash and short-term investments
    €9.06M
    Total receivables
    €1.09M
    Inventory
    €0.00
    Other current assets
    €120.12K
    Total current assets
    €10.28M
    Property, plant & equipment
    €429.86K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €292.58K
    Total non-current assets
    €722.44K
    Total assets
    €11.00M
    Accounts payable
    €420.42K
    Short-term debt
    €193.91K
    Other current liabilities
    €1.31M
    Total current liabilities
    €1.93M
    Long-term debt
    €153.58K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €153.58K
    Total liabilities
    €2.08M
    Common stock
    €0.00
    Retained earnings
    -€90.90M
    Other equity
    €0.00
    Total equity
    €8.92M
    Total liabilities and shareholders' equity
    €11.00M

    Company information

    Market capitalization
    €941.21K
    Employees
    20
    Enterprise Value
    -€4.60M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -128.9% Much better than peer group: -758.1%
    ROA
    -104.5% Much better than peer group: -423.4%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    0.0%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€574.86K

    Notifications